These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 26862825)

  • 1. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
    Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
    Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
    Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
    Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for BK Polyoma Virus Treatment and Association of Treatment With Kidney Transplant Failure: Insights From a Paired Kidney Analysis.
    Thangaraju S; Gill J; Wright A; Dong J; Rose C; Gill J
    Transplantation; 2016 Apr; 100(4):854-61. PubMed ID: 27003098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral infections directly involved in kidney allograft function.
    Masutani K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J; Feng S; Jiang Y; Wang W; Zhang X
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active management of post-renal transplantation BK virus nephropathy: preliminary report.
    Halim MA; Al-Otaibi T; El-Kholy O; Gheith OA; Al-Waheeb S; Szucs G; Pacsa A; Balaha MA; Hasaneen H; Said T; Nair P; Nampoory MR
    Transplant Proc; 2009 Sep; 41(7):2850-2. PubMed ID: 19765455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
    Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
    Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation.
    Schaenman JM; Korin Y; Sidwell T; Kandarian F; Harre N; Gjertson D; Lum EL; Reddy U; Huang E; Pham PT; Bunnapradist S; Danovitch GM; Veale J; Gritsch HA; Reed EF
    Transplantation; 2017 Jun; 101(6):1479-1487. PubMed ID: 27391197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.